Northrop Grumman (NOC) was upgraded to overweight from equal-weight at Barclays. $270 price target. The company is leveraged to higher overall spending, Barclays said.
OneMain (OMG) was downgraded to equal-weight at Barclays. $19 price target. The valuation is less attractive, as the company slashed earnings guidance, Barclays said.
WellCare Health Plans (WCG - Get Report) was downgraded to neutral from overweight at JPMorgan. $115 price target. The valuation is less attractive, as the company is facing new political risks, JPMorgan said.